E
Eikon Therapeutics, Inc. EIKN
$10.73 $0.020.19% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2026 03/31/2026 12/31/2025
Total Cash And Short-Term Investments -- 132.69% 52.64%
Total Receivables -- -- --
Inventory -- -- --
Prepaid Expenses -- -- 69.99%
Finance Division Loans and Leases Current -- -- --
Total Finance Division Other Current Assets -- -- --
Other Current Assets -- -- 0.00%
Total Current Assets -- -- 53.11%

Total Current Assets -- -- 53.11%
Net Property, Plant & Equipment -- -- -9.75%
Long-term Investments -- -- --
Goodwill -- -- --
Total Other Intangibles -- -- --
Finance Div Loans & Leases LT -- -- --
Total Finance Div Other LT Assets -- -- --
Total Other Assets -- -- 183.34%
Total Assets -- -- 21.07%

Total Accounts Payable -- -- -96.13%
Total Accrued Expenses -- -- 51.44%
Short-term Debt -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- --
Finance Division Debt Current -- -- 7.75%
Total Finance Division Other Current Liabilities -- -- -66.09%
Total Other Current Liabilities -- -- -66.09%
Total Current Liabilities -- -- -2.55%

Total Current Liabilities -- -- -2.55%
Long-Term Debt -- -- --
Short-term Debt -- -- --
Capital Leases -- -- 28.03%
Finance Division Debt Non Current -- -- --
Total Finance Division Other Non Current Liabilities -- -- --
Total Other Liabilities -- -- 86.99%
Total Liabilities -- -- 22.49%

Common Stock & APIC -- -- 25.64%
Retained Earnings -- -- -52.17%
Treasury Stock & Other -- -- --
Total Common Equity -- 196.28% -53.70%

Preferred Stock Redeemable -- -- --
Preferred Stock Non Redeemable -- -- --
Preferred Stock Convertible -- -- 43.71%
Preferred Stock, Others -- -- --
Total Preferred Equity -- -- 43.71%

Total Common Equity -- 196.28% -53.70%
Total Preferred Equity -- -- 43.71%
Total Minority Interest -- -- --
Total Equity -- 133.05% 19.53%